Your browser doesn't support javascript.
loading
Bax upregulation may provide a rationale for the low incidence of esophageal adenocarcinoma in a Greek cohort of patients with Barrett's esophagus.
Chatzopoulos, Dimitrios; Kyrgidis, Athanasios; Kountouras, Jannis; Zavos, Christos; Molyvas, Epaminondas; Venizelos, Ioannis.
Affiliation
  • Chatzopoulos D; Department of Medicine, Second Medical Clinic, Ippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Hepatogastroenterology ; 54(75): 705-9, 2007.
Article in En | MEDLINE | ID: mdl-17591046
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Barrett Esophagus / Esophageal Neoplasms / Adenocarcinoma / Bcl-2-Associated X Protein Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Hepatogastroenterology Year: 2007 Type: Article Affiliation country: Greece
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Barrett Esophagus / Esophageal Neoplasms / Adenocarcinoma / Bcl-2-Associated X Protein Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Hepatogastroenterology Year: 2007 Type: Article Affiliation country: Greece